Tubac, Chrissel .

HRN: 29-20-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CEFUROXIME 1.5GM (VIAL)
06/20/2026
06/26/2026
IV
430MG
Q8
UTI
Remove - Pending Acceptance
06/22/2026
CEFUROXIME 750MG (VIAL)
06/22/2026
06/29/2026
IV
430mg
Q8
Acute Bacterial Inection
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: